Nasdaq - Delayed Quote USD

ProFunds Biotechnology UltraSector Fund (BIPIX)

35.31
+0.84
+(2.44%)
At close: 8:04:13 PM EDT

Top 5 Holdings (11.10% of Total Assets)

SymbolCompany% Assets
Gilead Sciences, Inc. 2.33%
Amgen Inc. 2.22%
Sarepta Therapeutics, Inc. 2.20%
AbbVie Inc. 2.19%
Exact Sciences Corporation 2.17%

Sector Weightings

SectorBIPIX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 19.67%
Stocks 78.77%
Bonds 0.00%
Others -0.65%
Preferred 0.00%
Convertible 2.21%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average BIPIX Category Average
Price/Earnings 0 0
Price/Book 0.23 3.89
Price/Sales 0.13 2.3
Price/Cashflow 0 0
Median Market Cap 8,143.27 140,046.23
3 Year Earnings Growth 0 0

Bond Holdings

Average BIPIX Category Average
Maturity -- --
Duration 7 --
Credit Quality -- --

Performance & Risk

YTD Return -24.47%
5y Average Return -1.26%
Rank in Category (ytd) --
% Rank in Category (ytd) --
Beta (5Y Monthly) 1.45
Morningstar Risk Rating

Fund Overview

Category Trading--Leveraged Equity
Fund Family ProFunds
Net Assets 66.23M
YTD Return -14.00%
Yield 0.20%
Morningstar Rating
Inception Date Jun 19, 2000

Fund Summary

The index is designed to measure the performance of biotechnology companies included in the S&P Total Market Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Related Tickers